Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience

An advance of Hodgkin lymphoma (HL) diagnostic and treatment protocols promoted between fatal and high-curative disease. Modern treatment programs can reach many-year survival rate in 8097% even in patients with advanced (IIIIV) HL stages and unfavorable prognostic factors pre- sence. Nevertheless,...

Full description

Bibliographic Details
Main Authors: Natalia S. Tsaplina, Timur T. Valiev, Galina D. Petrova, Kirill I. Kirgizov, Svetlana R. Varfolomeeva
Format: Article
Language:Russian
Published: IP Habib O.N. 2022-11-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/109878/pdf